カテゴリー： Market Monitor Global, 世界, 医療/バイオ

CD74抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル

◆英語タイトル：CD74 Antibody Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12295）◆商品コード：MMG23DC12295
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：118
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のCD74抗体市場規模と予測を収録しています。・世界のCD74抗体市場：売上、2018年-2023年、2024年-2029年
・世界のCD74抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のCD74抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

CD74抗体のグローバル主要企業は、Merck、 Bioss、 BosterBio、 QED Bioscience、 Novus Biologicals、 GeneTex、 RayBiotech、 LifeSpan BioSciences、 EpiGentek、 Leading Biology、 ProSci、 NSJ Bioreagents、 OriGene Technologies、 BioLegend、 Bethyl Laboratories、 ABclonal Technology、 AssayPro、 Miltenyi Biotec、 Antigenix America Inc.、 G Biosciences、 Biobyt、 Jingjie PTM BioLabなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、CD74抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のCD74抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界のCD74抗体市場：タイプ別市場シェア、2022年
・モノクローナル、ポリクローナル

世界のCD74抗体市場：用途別、2018年-2023年、2024年-2029年
世界のCD74抗体市場：用途別市場シェア、2022年
・免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他

世界のCD74抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界のCD74抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるCD74抗体のグローバル売上、2018年-2023年
・主要企業におけるCD74抗体のグローバル売上シェア、2022年
・主要企業におけるCD74抗体のグローバル販売量、2018年-2023年
・主要企業におけるCD74抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck、 Bioss、 BosterBio、 QED Bioscience、 Novus Biologicals、 GeneTex、 RayBiotech、 LifeSpan BioSciences、 EpiGentek、 Leading Biology、 ProSci、 NSJ Bioreagents、 OriGene Technologies、 BioLegend、 Bethyl Laboratories、 ABclonal Technology、 AssayPro、 Miltenyi Biotec、 Antigenix America Inc.、 G Biosciences、 Biobyt、 Jingjie PTM BioLab

*************************************************************

・調査・分析レポートの概要
CD74抗体市場の定義
市場セグメント
世界のCD74抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のCD74抗体市場規模
世界のCD74抗体市場規模：2022年 VS 2029年
世界のCD74抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのCD74抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のCD74抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：モノクローナル、ポリクローナル
CD74抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他
CD74抗体の用途別グローバル売上・予測

・地域別市場分析
地域別CD74抗体市場規模 2022年と2029年
地域別CD74抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Bioss、 BosterBio、 QED Bioscience、 Novus Biologicals、 GeneTex、 RayBiotech、 LifeSpan BioSciences、 EpiGentek、 Leading Biology、 ProSci、 NSJ Bioreagents、 OriGene Technologies、 BioLegend、 Bethyl Laboratories、 ABclonal Technology、 AssayPro、 Miltenyi Biotec、 Antigenix America Inc.、 G Biosciences、 Biobyt、 Jingjie PTM BioLab
...

This research report provides a comprehensive analysis of the CD74 Antibody market, focusing on the current trends, market dynamics, and future prospects. The report explores the global CD74 Antibody market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of CD74 Antibody, challenges faced by the industry, and potential opportunities for market players.
The global CD74 Antibody market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The CD74 Antibody market presents opportunities for various stakeholders, including Immunochemistry (IHC), Immunofluorescence (IF). Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in CD74 Antibody market. Additionally, the growing consumer demand present avenues for market expansion.
The global CD74 Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the CD74 Antibody market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the CD74 Antibody market.
Market Overview: The report provides a comprehensive overview of the CD74 Antibody market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal, Polyclonal), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the CD74 Antibody market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the CD74 Antibody market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the CD74 Antibody market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the CD74 Antibody market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the CD74 Antibody market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the CD74 Antibody market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for CD74 Antibody, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the CD74 Antibody market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
CD74 Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal
Polyclonal
Market segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Global CD74 Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Merck
Bioss
BosterBio
QED Bioscience
Novus Biologicals
GeneTex
RayBiotech
LifeSpan BioSciences
EpiGentek
Leading Biology
ProSci
NSJ Bioreagents
OriGene Technologies
BioLegend
Bethyl Laboratories
ABclonal Technology
AssayPro
Miltenyi Biotec
Antigenix America Inc.
G Biosciences
Biobyt
Jingjie PTM BioLab
Outline of Major Chapters:
Chapter 1: Introduces the definition of CD74 Antibody, market overview.
Chapter 2: Global CD74 Antibody market size in revenue.
Chapter 3: Detailed analysis of CD74 Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CD74 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 CD74 Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CD74 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CD74 Antibody Overall Market Size
2.1 Global CD74 Antibody Market Size: 2022 VS 2029
2.2 Global CD74 Antibody Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CD74 Antibody Players in Global Market
3.2 Top Global CD74 Antibody Companies Ranked by Revenue
3.3 Global CD74 Antibody Revenue by Companies
3.4 Top 3 and Top 5 CD74 Antibody Companies in Global Market, by Revenue in 2022
3.5 Global Companies CD74 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 CD74 Antibody Players in Global Market
3.6.1 List of Global Tier 1 CD74 Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 CD74 Antibody Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global CD74 Antibody Market Size Markets, 2022 & 2029
4.1.2 Monoclonal
4.1.3 Polyclonal
4.2 By Type – Global CD74 Antibody Revenue & Forecasts
4.2.1 By Type – Global CD74 Antibody Revenue, 2018-2023
4.2.2 By Type – Global CD74 Antibody Revenue, 2024-2029
4.2.3 By Type – Global CD74 Antibody Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global CD74 Antibody Market Size, 2022 & 2029
5.1.2 Immunochemistry (IHC)
5.1.3 Immunofluorescence (IF)
5.1.4 Immunoprecipitation (IP)
5.1.5 Western Blot (WB)
5.1.6 ELISA
5.1.7 Others
5.2 By Application – Global CD74 Antibody Revenue & Forecasts
5.2.1 By Application – Global CD74 Antibody Revenue, 2018-2023
5.2.2 By Application – Global CD74 Antibody Revenue, 2024-2029
5.2.3 By Application – Global CD74 Antibody Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global CD74 Antibody Market Size, 2022 & 2029
6.2 By Region – Global CD74 Antibody Revenue & Forecasts
6.2.1 By Region – Global CD74 Antibody Revenue, 2018-2023
6.2.2 By Region – Global CD74 Antibody Revenue, 2024-2029
6.2.3 By Region – Global CD74 Antibody Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America CD74 Antibody Revenue, 2018-2029
6.3.2 US CD74 Antibody Market Size, 2018-2029
6.3.3 Canada CD74 Antibody Market Size, 2018-2029
6.3.4 Mexico CD74 Antibody Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe CD74 Antibody Revenue, 2018-2029
6.4.2 Germany CD74 Antibody Market Size, 2018-2029
6.4.3 France CD74 Antibody Market Size, 2018-2029
6.4.4 U.K. CD74 Antibody Market Size, 2018-2029
6.4.5 Italy CD74 Antibody Market Size, 2018-2029
6.4.6 Russia CD74 Antibody Market Size, 2018-2029
6.4.7 Nordic Countries CD74 Antibody Market Size, 2018-2029
6.4.8 Benelux CD74 Antibody Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia CD74 Antibody Revenue, 2018-2029
6.5.2 China CD74 Antibody Market Size, 2018-2029
6.5.3 Japan CD74 Antibody Market Size, 2018-2029
6.5.4 South Korea CD74 Antibody Market Size, 2018-2029
6.5.5 Southeast Asia CD74 Antibody Market Size, 2018-2029
6.5.6 India CD74 Antibody Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America CD74 Antibody Revenue, 2018-2029
6.6.2 Brazil CD74 Antibody Market Size, 2018-2029
6.6.3 Argentina CD74 Antibody Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa CD74 Antibody Revenue, 2018-2029
6.7.2 Turkey CD74 Antibody Market Size, 2018-2029
6.7.3 Israel CD74 Antibody Market Size, 2018-2029
6.7.4 Saudi Arabia CD74 Antibody Market Size, 2018-2029
6.7.5 UAE CD74 Antibody Market Size, 2018-2029
7 CD74 Antibody Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck CD74 Antibody Major Product Offerings
7.1.4 Merck CD74 Antibody Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Bioss
7.2.1 Bioss Company Summary
7.2.2 Bioss Business Overview
7.2.3 Bioss CD74 Antibody Major Product Offerings
7.2.4 Bioss CD74 Antibody Revenue in Global Market (2018-2023)
7.2.5 Bioss Key News & Latest Developments
7.3 BosterBio
7.3.1 BosterBio Company Summary
7.3.2 BosterBio Business Overview
7.3.3 BosterBio CD74 Antibody Major Product Offerings
7.3.4 BosterBio CD74 Antibody Revenue in Global Market (2018-2023)
7.3.5 BosterBio Key News & Latest Developments
7.4 QED Bioscience
7.4.1 QED Bioscience Company Summary
7.4.2 QED Bioscience Business Overview
7.4.3 QED Bioscience CD74 Antibody Major Product Offerings
7.4.4 QED Bioscience CD74 Antibody Revenue in Global Market (2018-2023)
7.4.5 QED Bioscience Key News & Latest Developments
7.5 Novus Biologicals
7.5.1 Novus Biologicals Company Summary
7.5.2 Novus Biologicals Business Overview
7.5.3 Novus Biologicals CD74 Antibody Major Product Offerings
7.5.4 Novus Biologicals CD74 Antibody Revenue in Global Market (2018-2023)
7.5.5 Novus Biologicals Key News & Latest Developments
7.6 GeneTex
7.6.1 GeneTex Company Summary
7.6.2 GeneTex Business Overview
7.6.3 GeneTex CD74 Antibody Major Product Offerings
7.6.4 GeneTex CD74 Antibody Revenue in Global Market (2018-2023)
7.6.5 GeneTex Key News & Latest Developments
7.7 RayBiotech
7.7.1 RayBiotech Company Summary
7.7.2 RayBiotech Business Overview
7.7.3 RayBiotech CD74 Antibody Major Product Offerings
7.7.4 RayBiotech CD74 Antibody Revenue in Global Market (2018-2023)
7.7.5 RayBiotech Key News & Latest Developments
7.8 LifeSpan BioSciences
7.8.1 LifeSpan BioSciences Company Summary
7.8.2 LifeSpan BioSciences Business Overview
7.8.3 LifeSpan BioSciences CD74 Antibody Major Product Offerings
7.8.4 LifeSpan BioSciences CD74 Antibody Revenue in Global Market (2018-2023)
7.8.5 LifeSpan BioSciences Key News & Latest Developments
7.9 EpiGentek
7.9.1 EpiGentek Company Summary
7.9.2 EpiGentek Business Overview
7.9.3 EpiGentek CD74 Antibody Major Product Offerings
7.9.4 EpiGentek CD74 Antibody Revenue in Global Market (2018-2023)
7.9.5 EpiGentek Key News & Latest Developments
7.10 Leading Biology
7.10.1 Leading Biology Company Summary
7.10.2 Leading Biology Business Overview
7.10.3 Leading Biology CD74 Antibody Major Product Offerings
7.10.4 Leading Biology CD74 Antibody Revenue in Global Market (2018-2023)
7.10.5 Leading Biology Key News & Latest Developments
7.11 ProSci
7.11.1 ProSci Company Summary
7.11.2 ProSci Business Overview
7.11.3 ProSci CD74 Antibody Major Product Offerings
7.11.4 ProSci CD74 Antibody Revenue in Global Market (2018-2023)
7.11.5 ProSci Key News & Latest Developments
7.12 NSJ Bioreagents
7.12.1 NSJ Bioreagents Company Summary
7.12.2 NSJ Bioreagents Business Overview
7.12.3 NSJ Bioreagents CD74 Antibody Major Product Offerings
7.12.4 NSJ Bioreagents CD74 Antibody Revenue in Global Market (2018-2023)
7.12.5 NSJ Bioreagents Key News & Latest Developments
7.13 OriGene Technologies
7.13.1 OriGene Technologies Company Summary
7.13.2 OriGene Technologies Business Overview
7.13.3 OriGene Technologies CD74 Antibody Major Product Offerings
7.13.4 OriGene Technologies CD74 Antibody Revenue in Global Market (2018-2023)
7.13.5 OriGene Technologies Key News & Latest Developments
7.14 BioLegend
7.14.1 BioLegend Company Summary
7.14.2 BioLegend Business Overview
7.14.3 BioLegend CD74 Antibody Major Product Offerings
7.14.4 BioLegend CD74 Antibody Revenue in Global Market (2018-2023)
7.14.5 BioLegend Key News & Latest Developments
7.15 Bethyl Laboratories
7.15.1 Bethyl Laboratories Company Summary
7.15.2 Bethyl Laboratories Business Overview
7.15.3 Bethyl Laboratories CD74 Antibody Major Product Offerings
7.15.4 Bethyl Laboratories CD74 Antibody Revenue in Global Market (2018-2023)
7.15.5 Bethyl Laboratories Key News & Latest Developments
7.16 ABclonal Technology
7.16.1 ABclonal Technology Company Summary
7.16.2 ABclonal Technology Business Overview
7.16.3 ABclonal Technology CD74 Antibody Major Product Offerings
7.16.4 ABclonal Technology CD74 Antibody Revenue in Global Market (2018-2023)
7.16.5 ABclonal Technology Key News & Latest Developments
7.17 AssayPro
7.17.1 AssayPro Company Summary
7.17.2 AssayPro Business Overview
7.17.3 AssayPro CD74 Antibody Major Product Offerings
7.17.4 AssayPro CD74 Antibody Revenue in Global Market (2018-2023)
7.17.5 AssayPro Key News & Latest Developments
7.18 Miltenyi Biotec
7.18.1 Miltenyi Biotec Company Summary
7.18.2 Miltenyi Biotec Business Overview
7.18.3 Miltenyi Biotec CD74 Antibody Major Product Offerings
7.18.4 Miltenyi Biotec CD74 Antibody Revenue in Global Market (2018-2023)
7.18.5 Miltenyi Biotec Key News & Latest Developments
7.19 Antigenix America Inc.
7.19.1 Antigenix America Inc. Company Summary
7.19.2 Antigenix America Inc. Business Overview
7.19.3 Antigenix America Inc. CD74 Antibody Major Product Offerings
7.19.4 Antigenix America Inc. CD74 Antibody Revenue in Global Market (2018-2023)
7.19.5 Antigenix America Inc. Key News & Latest Developments
7.20 G Biosciences
7.20.1 G Biosciences Company Summary
7.20.2 G Biosciences Business Overview
7.20.3 G Biosciences CD74 Antibody Major Product Offerings
7.20.4 G Biosciences CD74 Antibody Revenue in Global Market (2018-2023)
7.20.5 G Biosciences Key News & Latest Developments
7.21 Biobyt
7.21.1 Biobyt Company Summary
7.21.2 Biobyt Business Overview
7.21.3 Biobyt CD74 Antibody Major Product Offerings
7.21.4 Biobyt CD74 Antibody Revenue in Global Market (2018-2023)
7.21.5 Biobyt Key News & Latest Developments
7.22 Jingjie PTM BioLab
7.22.1 Jingjie PTM BioLab Company Summary
7.22.2 Jingjie PTM BioLab Business Overview
7.22.3 Jingjie PTM BioLab CD74 Antibody Major Product Offerings
7.22.4 Jingjie PTM BioLab CD74 Antibody Revenue in Global Market (2018-2023)
7.22.5 Jingjie PTM BioLab Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. CD74 Antibody Market Opportunities & Trends in Global Market
Table 2. CD74 Antibody Market Drivers in Global Market
Table 3. CD74 Antibody Market Restraints in Global Market
Table 4. Key Players of CD74 Antibody in Global Market
Table 5. Top CD74 Antibody Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CD74 Antibody Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CD74 Antibody Revenue Share by Companies, 2018-2023
Table 8. Global Companies CD74 Antibody Product Type
Table 9. List of Global Tier 1 CD74 Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD74 Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global CD74 Antibody Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - CD74 Antibody Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CD74 Antibody Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global CD74 Antibody Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - CD74 Antibody Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CD74 Antibody Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global CD74 Antibody Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global CD74 Antibody Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CD74 Antibody Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America CD74 Antibody Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CD74 Antibody Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe CD74 Antibody Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CD74 Antibody Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia CD74 Antibody Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CD74 Antibody Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America CD74 Antibody Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CD74 Antibody Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa CD74 Antibody Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CD74 Antibody Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck CD74 Antibody Product Offerings
Table 32. Merck CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Bioss Company Summary
Table 35. Bioss CD74 Antibody Product Offerings
Table 36. Bioss CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 37. Bioss Key News & Latest Developments
Table 38. BosterBio Company Summary
Table 39. BosterBio CD74 Antibody Product Offerings
Table 40. BosterBio CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 41. BosterBio Key News & Latest Developments
Table 42. QED Bioscience Company Summary
Table 43. QED Bioscience CD74 Antibody Product Offerings
Table 44. QED Bioscience CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 45. QED Bioscience Key News & Latest Developments
Table 46. Novus Biologicals Company Summary
Table 47. Novus Biologicals CD74 Antibody Product Offerings
Table 48. Novus Biologicals CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 49. Novus Biologicals Key News & Latest Developments
Table 50. GeneTex Company Summary
Table 51. GeneTex CD74 Antibody Product Offerings
Table 52. GeneTex CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 53. GeneTex Key News & Latest Developments
Table 54. RayBiotech Company Summary
Table 55. RayBiotech CD74 Antibody Product Offerings
Table 56. RayBiotech CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 57. RayBiotech Key News & Latest Developments
Table 58. LifeSpan BioSciences Company Summary
Table 59. LifeSpan BioSciences CD74 Antibody Product Offerings
Table 60. LifeSpan BioSciences CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 61. LifeSpan BioSciences Key News & Latest Developments
Table 62. EpiGentek Company Summary
Table 63. EpiGentek CD74 Antibody Product Offerings
Table 64. EpiGentek CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 65. EpiGentek Key News & Latest Developments
Table 66. Leading Biology Company Summary
Table 67. Leading Biology CD74 Antibody Product Offerings
Table 68. Leading Biology CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 69. Leading Biology Key News & Latest Developments
Table 70. ProSci Company Summary
Table 71. ProSci CD74 Antibody Product Offerings
Table 72. ProSci CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 73. ProSci Key News & Latest Developments
Table 74. NSJ Bioreagents Company Summary
Table 75. NSJ Bioreagents CD74 Antibody Product Offerings
Table 76. NSJ Bioreagents CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 77. NSJ Bioreagents Key News & Latest Developments
Table 78. OriGene Technologies Company Summary
Table 79. OriGene Technologies CD74 Antibody Product Offerings
Table 80. OriGene Technologies CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 81. OriGene Technologies Key News & Latest Developments
Table 82. BioLegend Company Summary
Table 83. BioLegend CD74 Antibody Product Offerings
Table 84. BioLegend CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 85. BioLegend Key News & Latest Developments
Table 86. Bethyl Laboratories Company Summary
Table 87. Bethyl Laboratories CD74 Antibody Product Offerings
Table 88. Bethyl Laboratories CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 89. Bethyl Laboratories Key News & Latest Developments
Table 90. ABclonal Technology Company Summary
Table 91. ABclonal Technology CD74 Antibody Product Offerings
Table 92. ABclonal Technology CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 93. ABclonal Technology Key News & Latest Developments
Table 94. AssayPro Company Summary
Table 95. AssayPro CD74 Antibody Product Offerings
Table 96. AssayPro CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 97. AssayPro Key News & Latest Developments
Table 98. Miltenyi Biotec Company Summary
Table 99. Miltenyi Biotec CD74 Antibody Product Offerings
Table 100. Miltenyi Biotec CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 101. Miltenyi Biotec Key News & Latest Developments
Table 102. Antigenix America Inc. Company Summary
Table 103. Antigenix America Inc. CD74 Antibody Product Offerings
Table 104. Antigenix America Inc. CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 105. Antigenix America Inc. Key News & Latest Developments
Table 106. G Biosciences Company Summary
Table 107. G Biosciences CD74 Antibody Product Offerings
Table 108. G Biosciences CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 109. G Biosciences Key News & Latest Developments
Table 110. Biobyt Company Summary
Table 111. Biobyt CD74 Antibody Product Offerings
Table 112. Biobyt CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 113. Biobyt Key News & Latest Developments
Table 114. Jingjie PTM BioLab Company Summary
Table 115. Jingjie PTM BioLab CD74 Antibody Product Offerings
Table 116. Jingjie PTM BioLab CD74 Antibody Revenue (US$, Mn) & (2018-2023)
Table 117. Jingjie PTM BioLab Key News & Latest Developments
List of Figures
Figure 1. CD74 Antibody Segment by Type in 2022
Figure 2. CD74 Antibody Segment by Application in 2022
Figure 3. Global CD74 Antibody Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CD74 Antibody Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CD74 Antibody Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CD74 Antibody Revenue in 2022
Figure 8. By Type - Global CD74 Antibody Revenue Market Share, 2018-2029
Figure 9. By Application - Global CD74 Antibody Revenue Market Share, 2018-2029
Figure 10. By Type - Global CD74 Antibody Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global CD74 Antibody Revenue Market Share, 2018-2029
Figure 12. By Application - Global CD74 Antibody Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global CD74 Antibody Revenue Market Share, 2018-2029
Figure 14. By Region - Global CD74 Antibody Revenue Market Share, 2018-2029
Figure 15. By Country - North America CD74 Antibody Revenue Market Share, 2018-2029
Figure 16. US CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 17. Canada CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe CD74 Antibody Revenue Market Share, 2018-2029
Figure 20. Germany CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 21. France CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 23. Italy CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 24. Russia CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia CD74 Antibody Revenue Market Share, 2018-2029
Figure 28. China CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 29. Japan CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 32. India CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America CD74 Antibody Revenue Market Share, 2018-2029
Figure 34. Brazil CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa CD74 Antibody Revenue Market Share, 2018-2029
Figure 37. Turkey CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 38. Israel CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 40. UAE CD74 Antibody Revenue, (US$, Mn), 2018-2029
Figure 41. Merck CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bioss CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BosterBio CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. QED Bioscience CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novus Biologicals CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GeneTex CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. RayBiotech CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. LifeSpan BioSciences CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. EpiGentek CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Leading Biology CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. ProSci CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. NSJ Bioreagents CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. OriGene Technologies CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. BioLegend CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Bethyl Laboratories CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. ABclonal Technology CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. AssayPro CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Miltenyi Biotec CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Antigenix America Inc. CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. G Biosciences CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Biobyt CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Jingjie PTM BioLab CD74 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ CD74抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル(CD74 Antibody Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • RIC8A抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • リン酸FAK抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • FIS1抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • 抗CD44抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • CD4抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル